» Authors » Michele Ciccarelli

Michele Ciccarelli

Explore the profile of Michele Ciccarelli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 193
Citations 4741
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Visco V, Forte M, Giallauria F, DAmbrosio L, Piccoli M, Schiattarella G, et al.
Int J Cardiol . 2025 Mar; :133166. PMID: 40088953
The benefits of cardiac rehabilitation (CR) have been demonstrated in patients after myocardial infarction (MI), and in patients with chronic heart failure (HF). The core components of the CR program...
2.
Mancusi C, Basile C, Fucile I, Palombo C, Lembo M, Buso G, et al.
High Blood Press Cardiovasc Prev . 2025 Mar; PMID: 40082374
In patient with arterial hypertension the whole aorta is exposed to increased wall stress due to pressure overload. Different blood pressure (BP) components have been reported as main determinant of...
3.
Bramanti A, Corallo A, Clemente G, Greco L, Garofano M, Giordano M, et al.
Healthcare (Basel) . 2025 Mar; 13(5). PMID: 40077080
Background: Non-communicable diseases (NCDs) represent a leading cause of global mortality, demanding innovative approaches to management. Voice assistants (VAs) have emerged as promising tools in healthcare, offering support for self-management,...
4.
Gatto C, Rusciano M, Visco V, Ciccarelli M
Int J Mol Sci . 2025 Mar; 26(5). PMID: 40076919
G protein-coupled receptors (GPCRs) represent a family of membrane proteins that regulate several cellular processes. Among the GPCRs, G protein-coupled receptor kinases (GRKs) regulate downstream signaling pathways and receptor desensitization....
5.
Russo E, Viazzi F, Pontremoli R, Angeli F, Barbagallo C, Berardino B, et al.
Lipids Health Dis . 2025 Jan; 24(1):21. PMID: 39856749
Background: Insulin resistance (IR) and serum uric acid (SUA) are closely interconnected: SUA contributes to adversely affects the insulin signaling pathway and contributes to IR, while IR is a known...
6.
Izzo C, Visco V, Cirillo A, Bonadies D, Caliendo G, Rusciano M, et al.
J Cardiovasc Dev Dis . 2024 Dec; 11(12). PMID: 39728279
Severe obesity is closely associated with an increased risk of comorbidities and alterations in cardiac structure and function. The primary objective of this study was to investigate cardiovascular (CV) risk...
7.
Loria F, Mone P, Rispoli A, Di Fonzo R, Masarone D, Mancusi C, et al.
Cardiovasc Diabetol . 2024 Nov; 23(1):423. PMID: 39578847
Background: Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i) represent a deep revolution of the therapeutic approach to heart failure (HF), preventing its insurgence but also improving the management of the disease and slowing...
8.
Di Pietro P, Abate A, Izzo C, Toni A, Rusciano M, Folliero V, et al.
Br J Pharmacol . 2024 Nov; 182(2):451-467. PMID: 39572402
No abstract available.
9.
Myasoedova V, Bertolini F, Valerio V, Moschetta D, Massaiu I, Rusconi V, et al.
Biomedicines . 2024 Sep; 12(9). PMID: 39335491
Background: Fibro-calcific aortic valve disease (FCAVD) is a progressive disorder characterized by the thickening and calcification of the aortic valve, eventually leading to aortic stenosis. Adiponectin and leptin, known for...
10.
Mone P, Ciccarelli M, Jankauskas S, Guerra G, Vecchione C, Visco V, et al.
Lancet Healthy Longev . 2024 Sep; 5(9):100632. PMID: 39284335
No abstract available.